Clinical laboratories certified under Clinical Laboratory Improvement Amendments can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19.
PerkinElmer's RT-PCR test is marketed as an in vitro diagnostic device by meeting the requirements of the European In Vitro Diagnostic Directive and is available in over 30 countries worldwide.
PerkinElmer offers solutions to serve the diagnostics, life sciences, food and applied markets.
The company reported revenue of approximately USD 2.9bn in 2019, serves customers in 190 countries, and is a component of the S and P 500 index.
US FDA approves Mylan and Fujifilm Kyowa Kirin Biologics' Hulio
Certis Oncology Solutions Launches Mobile COVID-19 Testing
US FDA Approves the First Injectable Treatment for Cellulite
LYNPARZA Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer
Ridgeback Biotherapeutics Starts Enrollment for Phase 2 Trial of Potential COVID-19 Treatment
Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19
Astex Pharmaceuticals' Inqovi tablets receive US FDA approval